Merus (MRUS) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free MRUS Stock Alerts $41.97 +1.15 (+2.82%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineValidea Detailed Fundamental Analysis - MRUSnasdaq.com - April 24 at 2:55 PMMerus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meetingglobenewswire.com - April 24 at 10:00 AMMerus (NASDAQ:MRUS) Receives Outperform Rating from William Blairamericanbankingnews.com - April 23 at 3:32 AMMerus (NASDAQ:MRUS) Earns Outperform Rating from William Blairmarketbeat.com - April 22 at 1:31 PMMerus (NASDAQ:MRUS) Receives Average Recommendation of "Buy" from Brokeragesamericanbankingnews.com - April 22 at 2:30 AMFederated Hermes Inc. Acquires 751,609 Shares of Merus (NASDAQ:MRUS)marketbeat.com - April 19 at 8:27 AM24,325 Shares in Merus (NASDAQ:MRUS) Acquired by HealthInvest Partners ABmarketbeat.com - April 16 at 6:50 PMMerus (NASDAQ:MRUS) Shares Purchased by DekaBank Deutsche Girozentralemarketbeat.com - April 15 at 5:08 AMNeedham & Company LLC Reaffirms Buy Rating for Merus (NASDAQ:MRUS)marketbeat.com - April 11 at 8:31 AMMerus reports progress on cancer therapy at AACR meetinginvesting.com - April 10 at 8:25 AMMerus N.V.: Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024finanznachrichten.de - April 8 at 2:44 PMMerus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024globenewswire.com - April 8 at 12:00 PMMerus (NASDAQ:MRUS) Shares Gap Up to $44.58marketbeat.com - April 4 at 1:20 PMMerus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 3 at 8:22 AMMerus (NASDAQ:MRUS) Earns Buy Rating from Analysts at Truist Financialmarketbeat.com - March 28 at 8:28 AMMerus (NASDAQ:MRUS) Shares Down 4% marketbeat.com - March 25 at 5:33 PMMerus (NASDAQ:MRUS) Shares Bought by Wellington Management Group LLPmarketbeat.com - March 19 at 4:54 AMHudson Bay Capital Management LP Boosts Stake in Merus (NASDAQ:MRUS)marketbeat.com - March 15 at 7:18 AMMerus (NASDAQ:MRUS) Shares Down 5.2% marketbeat.com - March 12 at 3:37 PMMerus (NASDAQ:MRUS) Shares Bought by Carmignac Gestionmarketbeat.com - March 12 at 12:43 PMMRUS Dec 2024 50.000 callfinance.yahoo.com - March 11 at 3:52 PMMRUS Jan 2025 50.000 putfinance.yahoo.com - March 10 at 1:07 AMMRUS Apr 2024 35.000 putfinance.yahoo.com - March 9 at 8:07 PMMRUS Apr 2024 40.000 callfinance.yahoo.com - March 9 at 8:07 PMGilead, Merus to Collaborate on Trispecific Antibody Researchmarketwatch.com - March 6 at 4:19 PMGilead to invest in Merus as part of a research dealmsn.com - March 6 at 4:19 PMMerus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expressionfinance.yahoo.com - March 6 at 4:19 PMGilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagersfinance.yahoo.com - March 6 at 4:19 PMRTW Investments LP Purchases 945,871 Shares of Merus (NASDAQ:MRUS)marketbeat.com - March 6 at 11:00 AMRock Springs Capital Management LP Purchases 359,897 Shares of Merus (NASDAQ:MRUS)marketbeat.com - March 5 at 7:21 PMMerus Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 5 at 2:06 PMStrong Buy Rating for Merus’s Peto: Anticipating High Market Potential and Synergistic Treatment Efficacymarkets.businessinsider.com - March 4 at 6:05 PMNeedham & Company LLC Raises Merus (NASDAQ:MRUS) Price Target to $65.00marketbeat.com - March 4 at 8:25 AMEarnings Update: Merus N.V. (NASDAQ:MRUS) Just Reported And Analysts Are Trimming Their Forecastsfinance.yahoo.com - March 2 at 12:58 PMMerus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancementseekingalpha.com - March 1 at 4:16 PMBraidwell LP Purchases 358,175 Shares of Merus (NASDAQ:MRUS)marketbeat.com - March 1 at 10:18 AMMerus’s Upgraded Outlook: Buy Rating and Price Target Boost Amid Promising Drug Trials and Financial Stabilitymarkets.businessinsider.com - March 1 at 9:52 AMQ1 2025 Earnings Estimate for Merus (NASDAQ:MRUS) Issued By William Blairmarketbeat.com - March 1 at 8:29 AMMRUS Apr 2024 40.000 putfinance.yahoo.com - February 29 at 11:08 PMStifel Nicolaus Keeps Their Buy Rating on Merus (MRUS)markets.businessinsider.com - February 29 at 6:07 PMHC Wainwright Boosts Merus (NASDAQ:MRUS) Price Target to $65.00marketbeat.com - February 29 at 3:47 PMBuy Rating Affirmed on Merus’s Stock Amid Strong Clinical Developments and Market Potentialmarkets.businessinsider.com - February 29 at 1:06 PMMerus N.V.: Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Updatefinanznachrichten.de - February 28 at 5:04 PMMerus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Updateglobenewswire.com - February 28 at 4:15 PMMerus (NASDAQ:MRUS) Hits New 12-Month High at $49.50marketbeat.com - February 28 at 11:29 AMAlgert Global LLC Sells 29,220 Shares of Merus (NASDAQ:MRUS)marketbeat.com - February 27 at 6:54 AMMonashee Investment Management LLC Takes Position in Merus (NASDAQ:MRUS)marketbeat.com - February 25 at 10:54 AMBarclays PLC Sells 62,369 Shares of Merus (NASDAQ:MRUS)marketbeat.com - February 20 at 4:17 AMSilverarc Capital Management LLC Trims Stock Position in Merus (NASDAQ:MRUS)marketbeat.com - February 18 at 12:53 PMMRUS Mar 2024 40.000 callfinance.yahoo.com - February 16 at 10:39 PM Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… MRUS Media Mentions By Week MRUS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRUS News Sentiment▼0.460.44▲Average Medical News Sentiment MRUS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRUS Articles This Week▼72▲MRUS Articles Average Week Get Merus News Delivered to You Automatically Sign up to receive the latest news and ratings for MRUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vera Therapeutics News Today Rhythm Pharmaceuticals News Today Corcept Therapeutics News Today Arvinas News Today Summit Therapeutics News Today Evotec News Today Rocket Pharmaceuticals News Today TG Therapeutics News Today Dyne Therapeutics News Today Janux Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRUS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merus Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
